Stay updated on Pirfenidone in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. No substantive changes to the trial details are evident.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded a new site revision indicator (v3.4.1) and removed the prior government-funding notice along with the earlier revision (v3.4.0).SummaryDifference0.5%

- Check40 days agoChange DetectedAdded a glossary toggle and updated metadata labels, including a new 'Revision: v3.4.0' and capitalization changes for 'No FEAR Act Data' versus 'No FEAR Act data'. Older QC-related wording such as 'Last Update Submitted that met QC Criteria' was replaced with 'Last Update Submitted that Met QC Criteria' and capitalization standardized; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check78 days agoChange DetectedLocations section added with a new site in Hubei, China. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check100 days agoChange DetectedThe revision history now shows Revision: v3.3.2 and removes Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.